Cargando…
CYB5R1 is a potential biomarker that correlates with stemness and drug resistance in gastric cancer
BACKGROUND: Drug resistance is a major obstacle in the treatment of gastric cancers (GC). In recent years, the prognostic value of the mRNA expression-based stemness score (mRNAss) across cancers has been reported. We intended to search for the key genes associated with Cancer stem cells (CSCs) and...
Autores principales: | Zhang, Qin, Ma, Yufan, Yan, Yongfeng, Zhang, Lu, Zhang, Yajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587760/ https://www.ncbi.nlm.nih.gov/pubmed/37844477 http://dx.doi.org/10.1016/j.tranon.2023.101766 |
Ejemplares similares
-
Assessing POR and CYB5R1 oxidoreductase-mediated oxidative rupture of PUFA in liposomes
por: Yan, Bo, et al.
Publicado: (2021) -
CYB5R3: a key player in aerobic metabolism and aging?
por: de Cabo, Rafael, et al.
Publicado: (2009) -
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer
por: Woischke, Christine, et al.
Publicado: (2016) -
The UFM1 system regulates ER-phagy through the ufmylation of CYB5R3
por: Ishimura, Ryosuke, et al.
Publicado: (2022) -
MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)